Zemvax, 39,680 Shares Net Bought by Individuals in Last 5 Days... Stock Price 26,250 Won (-1.32%)

As of 12:30 PM on the 23rd, ZEMVAX is trading at 26,250 KRW, down 1.32% from the previous day. The trading volume is 1,039,939 shares, which is about 47.32% of the previous day's volume. ZEMVAX is known as a manufacturer of contamination control equipment for the semiconductor and display sectors.

On September 21, researcher Oh Byung-yong from Hanyang Securities stated, "1) The full data from Phase 2 clinical trials and research results on the mechanism of action will soon be published in a paper, 2) Around October, a clinical trial plan and conditional marketing authorization application for domestic Phase 3 clinical trials are planned to be submitted. Additionally, 3) The expansion of the US clinical protocol is currently under discussion with the FDA, and the results of this consultation will be announced soon. Bio stocks attract market attention only when there are events. ZEMVAX has now reached a point where multiple events are concentrated. The stock price has not risen relatively much. It is a good time to buy." He set the target price for ZEMVAX at 45,000 KRW.

Over the past five days, individual investors have net purchased 39,680 shares of ZEMVAX, while foreigners and institutions have net sold 35,817 shares and net purchased 25,872 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.